Europe South Asia Asia Pacific Americas Middle East Africa BBC Homepage World Service Education



Front Page

World

UK

UK Politics

Business

Sci/Tech

Health

Education

Sport

Entertainment

Talking Point

In Depth

On Air

Archive
Feedback
Low Graphics
Help

Monday, June 21, 1999 Published at 15:44 GMT 16:44 UK


Health

Lymphoma breakthrough halts tumour growth

Gene therapy could hold the key to stopping tumour growth

Treatments which could prevent cancer cells from multiplying could reduce the need for damaging chemotherapy or radiotherapy for some patients.

Canadian research, focused on Hodgkin's Lymphoma, a cancer of the immune system which affects mainly young men, has identified the particular chemical which allows tumour cells to multiply rapidly.

When the chemical was removed, the cancer cells simply stopped growing.

Most Hodgkin's patients are treated with chemotherapy, radiotherapy or a combination of the two.

Scientists found that Interleukin-13, a growth factor, is released by Reed-Sternberg cells, which are the typical cancer cells found in Hodgkin's patients.

Prompts cells to multiply

It appears to be the chemical signal for the Reed-Sternberg cells to reproduce, making the tumour larger and increasing the risk of the cancer spreading.

An examination of genes taken from 950 tumours found IL-13 present in most.


[ image: Chemotherapy can have dangerous long term effects]
Chemotherapy can have dangerous long term effects
Dr Tak W. Mak, senior scientist at the Ontario Cancer Institute, said: "I'm particularly excited because for the first time we have identified the engine that drives at least some Hodgkin's cancer cells to multiply.

"We are now working to find a way to shut down that engine. These findings have huge clinical potential."

Test tube experiments found that tumour cells deprived of their supply of IL-13 simply stopped growing.

Gene technology may now be the way to deal with or block Interleukin-13 production from cancer cells.

Dr Ursula Kapp, from the University Medical Centre in Freiburg, Germany, said: "Now we know IL-13 plays a major role in the growth of at least some Hodgkin's tumours, we can begin to look at new treatments using IL-13 neutralising antibodies or by blocking IL-13 production altogether within Reed-Sternberg cells."

Side effects are dangerous

An alternative, particularly to chemotherapy for Hodgkin's is desirable, particularly as doctors are uncovering long term effects of the powerful treatments used to kill cancer cells, which can be as dangerous as the initial disease itself.

Although the cure rate for Hodgkin's is around four in five, a significant number of patients are falling prey to other cancers, heart disease or, more usually, infertility.

Hodgkin's is a cancer which is often found in people in their 20s and 30s, and affects, in the first instance, tissue of the lymphatic system in the neck, armpits, chest and groin.





Advanced options | Search tips




Back to top | BBC News Home | BBC Homepage | ©


Health Contents

Background Briefings
Medical notes

Relevant Stories

29 Apr 99 | Health
Drug starves cancer tumours

27 Apr 99 | Health
Doctors investigate 'bowel cancer gene'

21 Apr 99 | Health
Gene repair breakthrough

31 Mar 99 | Health
Gene therapy 'could treat brain cancer'

31 Mar 99 | Health
Cloned embryos 'could treat leukaemia'

08 Jan 99 | Health
Cancer gene breakthrough





Internet Links


Imperial Cancer Research Fund

Lymphoma Association

Hodgkin's Disease and Lymphoma Association


The BBC is not responsible for the content of external internet sites.




In this section

Disability in depth

Spotlight: Bristol inquiry

Antibiotics: A fading wonder

Mental health: An overview

Alternative medicine: A growth industry

The meningitis files

Long-term care: A special report

Aids up close

From cradle to grave

NHS reforms: A guide

NHS Performance 1999

From Special Report
NHS in crisis: Special report

British Medical Association conference '99

Royal College of Nursing conference '99